People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CardioMech AS | — | Biotechnology | Series B | $57.7M | $89.1M | 2025 |
Jan Habrekke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jan Habrekke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Novotny | 1 | 2 |
| Richard Nehm | 1 | 1 |
| Florian Eckhardt | 1 | 1 |
| Vic, Jr. Bertrand | 1 | 1 |
| Jacob Bergsland | 1 | 1 |
| Vic Bertrand, Jr. | 1 | 1 |
| Jacob Justin Gabriel Bergsland | 1 | 1 |
| Frederik Justin Gabriel Groenewegen | 1 | 1 |
| Vic Joseph Bertrand | 1 | 1 |
| Nikolai Hiorth | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.